The lima success story -whither other arterial grafts -are vein grafts obsolete ?

British Journal of Clinical Practice

Volumn 50, Issue 3, 1996, Pages 144-150

  Cooper, G J ^a,c   Underwood', M J ^b   Deverall, P B ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b BRISTOL ROYAL INFIRMARY   (United Kingdom)

^c NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERY GRAFT; CORONARY ARTERY BYPASS GRAFT; GRAFT OCCLUSION; GRAFT PATENCY; HEART MUSCLE REVASCULARIZATION; HUMAN; INTERNAL MAMMARY ARTERY; PRIORITY JOURNAL; REVIEW; SAPHENOUS VEIN GRAFT; SURVIVAL;

CORONARY ARTERY BYPASS; GRAFT OCCLUSION, VASCULAR; GRAFT SURVIVAL; HUMANS; MAMMARY ARTERIES; MICROSCOPY, ELECTRON, SCANNING; MYOCARDIAL REVASCULARIZATION; SAPHENOUS VEIN;

EID: 0029935362     PISSN: 00070947     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (131)

1. Campeau L. Crochet D, Lesperance J el al. Postoperative changes in aortocoronary saphenous vein gratis revisited. Angiographie studies at two weeks and at one year in two consecutive series of patients. Circulation 1975; 52; 369-377.
2. Fitzgibbon GM, Burton JR. Leach AJ. Coronary bypass graft fate. Angiographie grading of 1400 consecutive grafts early after operation and of 1132 after one year. Cm-ulation 1978:57: 1070-1074.
3. Chesebro JH. Clements IP, Fuster V et al. Aplatelet inhibitor drug irial in coronary artery bypass operations: benefit of peri-operative dipyridamole and aspirin therapy on early postoperative vein graft patency. N Eng J Med 1982: 307: 73-78.
4. Carrier M, Perault L, Pelletier LC. Reoperalion for coronary artery bypass grafting. Cardiovasc Clinic 1991; 21: 257-263.
5. Lytle BW, Cosgrove DM. Loop FD. Future implications of current trends in bypass surgery. Cardiovasc Clinic 1991; 21: 265-278.
6. Ivert TS. Ekestrom S, Petejfy A, Welti R. Coronary artery reoperations. Early and late results in 101 patients. Scand.I Thorac Cardiovasc Sug 1988; 22: 111-118.
7. Nair UR, Campbell CC, Dark JF et al. Reoperation for recurrent coronary artery and graft disease. A review of 73 patients in a group of 2573 consecutive first time opoerations. J Cardiovasc Surg 1989; 30: 656-660.
8. Dougenis S, Naik F, Hedley Brown A. Is repeat coronary surgery for recurrent angina cost effective? Ew Hear! J 1992; 13: 9-14.
9. Loop FD, Lytle BW, Cosgrove DM et al. Influence of the internal mammary artery graft on 10 year survival and other cardiac events. N Engl J Metl 1986; 314: 1-6.
10. van Son JAM. Smedts F. Vincent JG. Van Lier HJ, Kabat K. Comparative anatomic studies of various arterial grafts for myocardial revascularization. J Thorac Cardiovasc Surg 1990; 99: 703-707.
11. Sims FH. Discontinuities in the internal elastic lamina: a comparison of coronary and internal mammary arteries. Arterv 1985: 13: 127-143.
12. Kay H, Kous ME. Flernma RJ, Tector AJ, Lepley D. Atherosclerosis of the internal mammary artery. Ann Thorac Surg 1976; 21: 504-507.
13. Mestres CH, Rives A, Igual A, Vehi C. Matra M. Atherosclerosis of the internal mammary artery. Histopathological analysis and inplications of the results in CABG surgery. Thorac Cardiovasc Surg 1986; 34: 356-358.
14. SistoT, Isola J. Incidence of atherosclerosis in the internal mammary artery. Ann Thorac Surg 1989; 47: 884-886.
15. Sims FH. A comparison of coronary and internal mammary arteries and implicatons of the results in the etiology of atherosclerosis. Am Heart J 1983; 105: 560-566.
16. Suma H, Takanaski R. Atherosclerosis of the gastroepiploic and internal thoracic arteries. Ann Thorac Surg 1990; 50: 413-416.
17. Kalan JM, Roberts WC. Comparison of morphologic changes and luminal sizes of saphenous vein and internal mammary artery after simultaneous implantation for coronary artery bypass grafting. Am J Cardiol 1987; 60: 193-196.
18. Wahba A. Offerdal K. von Sommoggy, Birnbaum DE. The morphology of the inferior epigastric artery has implications on its use as a conduit for myocardial revascularization. Eitr J Cardiothorac Surg 1994; 8: 236-239.
19. Takayama T. Suma H, Wanibuchi Y, Tohda E, Matsunaka T, Yamashita S. Physiological and pharmacoloical responses of arterial graft flow after coronary artery bypass grafting measured with an implantable Doppier miniprobe. Cin idation 1992; 86(Suppl HI): II-217-II-223.
20. Singh RN. Beg RA, Kay EB. Physiological adaptability: The secret of success of the internal mammary artery graft. Ann Thorac Surg 1986; 41: 247-250.
21. Singh RN, Sosa JA. Internal mammary artery. A 'live' conduit for coronary bypass. J Thorac Cardiovasc Surg 1984; 87: 936-938.
22. Cremer J, Mugge A, Schulze M et al. The inferior epigastric artery for coronary bypass grafting. Functional assessment and clinical results. Eur J Cardio thorac Surg 1993:7:423-427.
23. Bjork VO, Ivert T, Landou C. Angiographie changes in internal mammary artery and saphenous vein grafts 2 weeks. I year and 5 years after coronary artery bypass grafting. Scand J Thorac Cardiovasc Surg 1981; 15: 23-30.
24. Ivert T, Huttunen K, Landou C, Bjork VO. Angiographie studies of internal mammary artery grafts 11 years after coronary artery bypass. J Thorac Cardiovasc Surg 1988:96: 1-12.
25. Isomura T. Hisatomi K, Hirano A, Ohishi K. Inoue O, Kalo H. The righl gastroepiploic artery and ils growth potential. J Thorac Carditmisc Surx 1994; 108: 592-593.
26. Vanhoutte PM. Houston DS. Platelets, endothelium and vasospam. Circulation 1985:72:728-735.
27. Chaikhouni A. Crawford HA. Kochel PJ, Olanoff LS. Halushka PV. Human internal mammary artery produces more prostacyelin than saphenous vein. J Thorac Ctmlitmisc Surx 1986: 92: 88-91.
28. Dohrin P. Canfield T. Moran J, Sullivan H. Pifarre R. Coronary artery bypass. The physiological basis for differences in flow with internal mammary artery and saphenous vein grafts. J Thorac Cardlovasc Smy 1977: 74: 445-454.
29. Subramaniim VA. Hernandez Y. Tack Goldman K. Grabowski EF. Weksler BB. Prostacyelin production by internal mammary as a factor in coronary artery bypass grafts. Surxerv 1986: 100: 376-382.
30. Oku T. Yarnane S. Suma H et al. Comparison of prostacyelin production of human gastroepiploic artery and saphenous vein. Ann Thorac S my 1990: 4M: 767-771).
31. l- LuscherTF. Diedrich D. Sibenmann R et al. Difference between endoteliurn-dependant relaxation in arterial and venous coronary bypass grafts. N Engl J Med 1988: 319:462-467.
32. Pearson PJ. Evora PR, Schaff HV. Bioassay of EDRF from internal mammary arteries: Implications for early and late bypass graft patency. Ann Thorac Surg 992; 54: 1078-1084.
33. Sala A. Rona P. Pompilio G et al. Prostacyelin production by different grafts employed in coronary operations. Ann Thorac Surg 1994; 57: 1147-1150.
34. Yang 7, Stultz P. von Segesser L. Bauer E. Turina M. Luseher T. Different interactions between platelets with arterial and venous coronary bypass vessels. Lancet 1991; 337: 939-943.
35. Alien SP. Chester AH. Dashwood MR. Tadjkarimi S. Piper PJ. Yacoub MH. Preferential vasoconstriction to cysteinyl leukotrines in the human saphenous vein compared with the internal mammary artery. Implications for graft performance. Ciirnltition 1994:90: 515-524.
36. Li XN. Stulz P. Siebenmann PR. Yang Z. Luscher IF. Different effects of activated platelets in the right gastroepiploic and internal mammary arteries. J Thorite Canlnmi M Surg 1992: 104: 1294-1302.
37. Luu TN. Chester AH. O'Neil GS et al. Different responses of the human gastmepiploic and internal mammary arteries to vasoactive peptides. Am J Physiol 1993:264: 83-87.
38. Luu TN. Dashwood MR. Chester AH. Tadjkarimi S. Yacoub MH. Action of vasoactive intestinal peptide and distribution of its binding sites in vessels used for coronary arlery bypass grafts. Am J Canliol 1993: 71: 1278-1282.
39. Fujiwara T. Kajiya F. Kanazawa S et al. Comparison of blood How velocity waveforms in different coronary artery bypass grafts. Sequential saphenous vein crafts and internal mammary artery grafts. Circulation 19X8; 78: 1210-1217.
40. de Bonn DP. Samani NJ. Spyl TJ. Hartshorne T. Thrush AJ. Evans DH. Transcutaneous ultrasound measurement of blood How in internal mammary artery to coronary artery grafts. Lancet 1992:339: 379-381.
41. Bach RG. Kern MJ. Donohue TJ. Aguirre FV. Caracciolo EA. Comparison ot phasic blood flow velocity characteristics of arterial and venous coronary artery bypass conduits. Cm nlaîi'on 1993; 88(Suppl 11): 11-133-11-140.
42. Mauric A. de Bono DP. Samani NJ. Spy t TJ. Hartshone T. Evans DH. Transcutaneous ultrasound assessment of internai thoracic artery to coronary artery grafts in patients w ith and without ischaemic symptoms. Br Heart J 1994: 72: 476-48 1.
43. Fusejima K. Takahara Y. Sudo Y. Murayama H. Masuda Y. Inagaki Y Comparison of coronary hemodynamies in patients with internal mammary artery and saphenous vein coronary artery bypass grafts: A noninvasive approach using combined two-dimensional and Dopplerechocardiography. J Am Coll Cardiol 1990; 15: 131-139.
44. Rubanyi GM, Romero JC. Vanhoutte PM. Flow induced release of endothelium derived relaxant factor. Am J Phy^iol 19X6: 250: H l I45-H 1149.
45. Diamond SL. Esktn SG. Mcintire LV. Fluid How stimulates tissue plasminogen activator secretion by cultured human endothelial cells. Science 1989: 243: 1483-1485.
46. Sharetkin JB. Diamond SL. Eskin SG. Mcintire LV. Diffenhach CW. Fluid flow decreases proendothelin niRNA levels and suppresses endolhelin-1 peptide release in cultured human endothelial cells. J I cJ.si Snri> 1991; 14: 1-9.
47. Lawrence MB. Smith CW, Eskin SG. Mcintire LV. Effect of venous shear stress on CD-18 mediated neutrophil adhesion to cultured endothelium. Blood 1990; 75: 227-237.
48. Slerpetti AV. Cucina A. D'Angelo LS. Cardillo B. Cavallaro A. Shear stress modulates the proliferation rale, protein synthesis and mitogenie activity of arterial smooth muscle cells. Snidery 1993; 113: 691-699.
49. Langille L. O'Donnell F. Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium dependent. Science 1986; 231: 405-407.
50. Glagov S. Zrius C. Giddens DP. Ku DN. Hemodynamies and atherosclerosis. Insiühts and perspectives tiained from studies of human arteries. An h Pathol Lah Med 19X8: 112: 1018-1031.
51. Zeff RH. Kangtahwom C, lannone LA et al. Internal mammary artery versus saphenous vein to the left anterior descending coronary artery. Prospective randomised study with 10 year follow up. Ann Thorm Smy 1988; 45: 533-536.
52. Cosgrove DM. Loop FD. Lytle B W et al. Determinants of K) year survival after primary myocardial revascularisation. Ann Surg 1985; 202: 480-490.
53. Cameron A. Kemp HG. Green GE. Bypass surgery with the internal mammary artery graft: 15 year follow up. Circulation 1986; 74(Suppl III): 111-30-111-36.
54. Geha AS. Hammond GL. Stephen RN et al. Long term outcome of revascularisation of the anterior coronary arteries with crossed double internal mammary vs saphenous vein grafts. Surgery 1987: 102: 667-673.
55. Cameron A. Davis KB. Green GE. Myers WO, Petlinger M. Clinical implications of internal mammary artery, grafts: The coronary artery surgery study experience. Cin-ulatitm 1988: 77: 815-X19.
56. Lytle BW. Loop FD. Thurcr RL. Groves LK. Taylor PC. Cosgrove DM. Isolated left anterior descending coronary atherosclerosis: Long term comparison of internal mammary artery and venous autografts. Cin-tiltiliati 1980; 61: 869-874.
57. van der Meer. Hillege HL. van Gilst WH et al. A comparison of internal mammary artery and saphenous vein grafts after coronary artery bypass surgery. Circulation 1994: 90: 2367-2374.
58. Goldman S. Copcland J. Moritz T et al. Internal mammary artery and saphenous vein patency: effects of aspirin. Cimilatinn 1990: 82(Suppl IV): IV-237-1V-242.
59. Okies JE. Page US. Bigelow JC et al. The left internal mammary artery: The graft of choice. Circulation 1984: 70(Suppl 11:1-213-1-221.
60. Lvtle BW. Loop FD. Cosgrove DM. Ratliff NB. Easley K. Taylor PC'. Long term (5-12 years) serial studies of internal mammary artery and saphenous vein coronary bypass grafts. J 1'linrat CanKontsc Surs; 1985: 89: 248-258.
61. Cosgrove DM. Lytle BW. Loop FD et al. Does bilateral internal mammary artery grafting increase surgical risk? J Thorat Canliovuxc Sun; 1988: 95: 850-856.
62. Kouchnukos NT Wareing TH. Murphy SF. Pelate C. Marshall WG. Risks of bilateral internal mammary artery bypass grafting. Ann Thurac Sun; 1990; 49: 210-217.
63. Lytle BW. Cosgrove DM. Saltus GL. Tayloi PC, Loop FD. Multives.se! coronary revascularisation without saphenous vein: Long term results of bilateral internal mammary arter}' grafting. Ann Thorac Surg 1983: 36: 540-547.
64. Morris JJ. Smith LR. Glower DG el al. Clinical evaluation of single vs multiple mammary artery bvpass. On illation 1990: 82(Suppl Ill): 1II-37-III-52.
65. Fiore AC. Naunheim KS. Dean Pet al. Results of internal thoracic artery grafting over 15 years: single v s double grafts. Ann 'I liorai Suri; 1990: 49: 202-209.
66. Naunheitn KS. Barner HB. Fiore AC. Results of internal thoracic artery grafting over 15 years: single vs double grafts. Ann Thiorat Sun; 1992: 53: 716-718.
67. Dion R. Verfielst R. Rousseau M et al. Sequential mammary giafthig. J Tlmrni Cimlionisc Sitrt; 1989: 98: 80-89.
68. Rankin JS. Newman GE. Bashore TM et al. Clinical and angiographie assessment of complex mammary artery bypass grafting. J 1 Itortic Ciirdinvitu Snrt; 1986; 92: 832-846.
69. Galhut DL. Traad EA. Dorman MJ el al. Seventeen year experience with bilateral internal mammary artery grafts. Aim Tlntrac Sun; 1990: 49: 195-201.
70. Huddlestone CB. Sloney WS. Alford WC et al. Internal tnamrnary arten gratis: Technical factors intluencing patency Ann Thhorac surg 1986; 42: 543-549.
71. Suma H. Wanibuchi V. Furuta S. Takeuchi A. Does use of the gastrocpiploic artery graft increase surgical risk?. J Throc Cardiovasec Stirs; 1991: 101: 121-125.
72. Caes FL. Francois B. van Nooten GJ. Transdiaphragmatic herniation of the stomach after right gastroepiploic artery grafting. J Thoruc Ctii'tlioviiM Snrg 1994: 108: 191-193.
73. PasicM. Carrel T. von Segesser L. Tui Ina M. Postoperative diaphragmatic hernia after use of the right gastroepiploic artery tor coronary bypass grafting. J Throic Cunlionise Sun; 1994: 108: 189-191.
74. WitkopJ. Dillemans BRS. Grandjean JG. Bams JL. Ebels T. Gastric perforation after aortocoronarv hvpass grafting with the right gastroepiploic arterv. Ann Throc Surs; 1994:58: 1170-1171.
75. Lytle BW. Cosgrove DM. Ratliff NB. Loop FD. Coronary artery bypass grafting with the right gastroepiploic arten, J Tliorac Cunliinwcse Sursi 1989: 97: 826-831.
76. Pym J. Brow n FM. Charrette FJP. Parker JO. West RO. Gastroepiploic-coronary anastomosis. J Thorns Canliovaw Sun; 1987:94: 256-259.
77. Gallo I. Saenz A. Alonso C et al. In situ right gastroepiploic artery. A conduit tor coronarv revascularisation. F-nr .1 Cardiothorac Surs; 1991; 5: 34-36.
78. Grandjcan JCi. Boonstra PW. den Hever P, Ebels T. Arterial revascularisation with the richl gaslroepiploic artery and internal mamman arteries in 300 patients. J ï' coracCM-tlnnav Slut; 1994: 107: 1309-1315.
79. Perrault LP. Carrier M. Hébert Y. Cartier R. Ledere Y. Pelletier LC. Early experience with the inferior epigastric artery in coronary arterv bypass grafting. A word of caution.,I Thornc CarJiinmt ,Surg 1993: 106: 928-930.
80. Buche M. Schoevaerdts 1C. Louagie Yet al. lise of the inferior epigastric aneiy lor coronarv bypass. J Thinrti; Curilionin Stirj 1992; 103:665-670.
81. Sanz G. Pajaron A. Alegna R et al and the Grupo Espanol para el Seguimiento del Injcrto Coronario (GES1C). Prevention of early aortocoronarv In pass occlusion by low-ilose aspirin and dipyndamole. Cirftiliitknn 1990: 82: 765-773.
82. Grondin C'M. C'ampeau L, Lesperance J et al. Comparison of late changes in internal mammary arterv and saphenous vein grafts in two consecnlive series of patients 10 vears after operation. Circulation 1984: 70lSuppl II: I-208-I-212.
83. FitJ.gibbon GM. Leach AJ. Kafka HP. Keon W.I. Coronarv bvpass graft fate: long-term angiographie study J Am Coll Ctmliol 1991: 17: 1075-1080.
84. Lam JYT. Soh'inoss BC. C'ampeau L. Platelets and thrombosis in vein graft occlusion: role ami prevention. cardui sr Clin 199 1; 21(21: 67-8 I.
85. Bourassa MG. Lesperance J. C'ampeau L. Simard P. Factors influencing palencv of aortocoronarv vein grafts. Circulation1972: 65lSuppl I): 1-79-1-85.
86. Goldman S. Copeland J. Moritz T et al. Saphenous vein graft patency I year after coronarv artery bypass surgerv and the effects of anlipiatelet therapy. Results of a Veterans Administration Cooperative Study Circulatinn 1989: 80: 1190-1197.
87. Pfisterer VI. Burkart F. Jockers C! et al. Trial of low-dose aspirin plus dipyridamole versus anticoagulants for prevention of aorlocnronary vein graft occlusion. Lancet 1989; ii: 1-7.
88. Zajtchuk R. Collins CiJ. Hollev PW et al. Coagulation factors influencing thrombosis of aorta-coronary bypass grafts. J Thorite Cdrtiumiti Suit; 1977: 73: 309-311.
89. Gavaghan TP, Hickie JB, Krilis SAet al. Increased plasma beta-thromboglobulin in patients wilh coronary artery vein graft occlusion: response to low-dose aspirin. J Am Coll Cardiol 1990; 15: 1250-1258.
90. Baumann FG, Catinella FP, Cunningham JN, Spencer FC. Vein contraction and smooth muscle cell extensions as causes of endothelial damage during graft preparation. Ann Sura 1981; 2: 199-211.
91. Angelini GD. Passani SL. Breckenridge IM, Newby AC. Nature and pressure dependence of damage induced by distention of human saphenous vein coronary artery bypass grafts. Cardiavasc Res 1987; 21: 902-907.
92. Angelini GD, Bryan AJ, Williams HMJ et al. Distention promotes platelet and leucocyte adhesion and reduces short-term patency in pig arterio-venous bypass grafts. J Thorac Cardiovasc Surg 1990; 99: 433-439.
93. Angelini GD, Bryan AJ, Hunter S, Newby AC. A surgical technique that preserves human saphenous vein functional integrity. Ann Thorac Surig 1992; 53: 871-874.
94. Angelini GD, Bryan AJ, West RR et al. Coronary artery bypass surgery: current practice in the United Kingdom. Thorax 1989; 44: 721-724.
95. Josa M, Lie JT, Bianco RL, Kaye MP. Reduction of thrombosis in canine coronary bypass vein grafts with dipyridamole and aspirin. Am J Cardiol 1981 ; 24: 1248-1254.
96. Chesebro JH, Fuster V. Drug trials in prevention of occlusion of aortocoronary artery vein grafts. J Thorac Cardiovasc Surg 1982; 83: 90-93.
97. Goldman S, Copeland J, Moritz T et al. Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy. Circulation 1988; 77: 1324-1332.
98. Brown BG. CukinghamRA. DeRouenTetal. Improved graft patency in patients treated with platelet-inhibiting therapy after coronary bypass surgery. Circulation 1985:72: 138-146.
99. Lorenz RL. Schacky CV, Weber M, Meister W. Kotzur J, Reichardt B et al. Improved aortocoronary bypass patency by low-dose aspirin ( 100mg daily). Lancet 1984; i: 1261-1264.
100. Goldman S, Copeland JG, Moritz T el al. Starting aspirin therapy after operation: effects on early graft patency. Circulation 1991; 84: 520-526.
101. Underwood MJ. More RS, Gershlick AH, de Bono DP. The effect of locally applied tissuetypc plasminogen activator on venous fibrinolytic activity: in-vitro and in-vivo investigations. Cardiovasc Res 1993; 27: 2270-2274.
102. Underwood MJ, Cooper GJ, More RS, Coumbe A, Toner C, Reynolds P, de Bono DP Locally applied tissue-type plasminogen activator enhances the fibrinolytic activity of experimental vein grafts and reduces micro-thrombus formation. Clin Sei 1995:88: 19A.
103. Reidy MA. Factors controlling smooth-muscle cell proliferation. Arch Path LabMed 1992; 116: 1276-1280.
104. Bourassa MG, Campeau L, Lesperance J. Grondin CM. Changes in grafts and coronary arteries after saphenous vein aortocoronary bypass surgery: results at repeat angiography. Circulation 1982; 65(Suppl II): II-90-II-97.
105. Campeau L. Enjalbert M, Lesperance J et al. Atherosclerosis and late closure of aortocoronary saphenous vein grafts: sequential angiographie studies at 2 weeks. 1 year, 5 to 7 years, and 10 to 12 years after surgery. Circulation 198.3: 68(Suppl II): II-1-II-7.
106. Unni KK, Kottke BA, Titus JL et al. Pathological changes in aortocoronary saphenous vein grafts. Am J Cardiol 1974; 34: 526-532.
107. Campeau L, Enjalbert M, Lesperance J et al. The relation of risk factors to the development of atherosclerosis in saphenous vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery. N EIIK J Med 1984; 311: I 329-1332.
108. Bourassa MG, Campeau L. Lesperance J. Changes in grafts and in coronary arteries after coronary bypass surgery. Cardimasc Clin 1991; 21(2): 83-100.
109. Soyombo M, Angelini GD, Newby AC. Neointima formation is promoted by surgical preparation and inhibited by cyclic nucleotides in human saphenous vein organ cultures. J Thorac Cardiovasc Surg 1995; 109: 2-12.
110. Zwolak RM, Adams MC, Clowes AW. Kinetics of vein graft hyperplasia: association with tangential stress. J Vase Surg 1987; 5: 126-136.
111. Golden MA, Au YPT, Kenagy RD, Clowes AW. Growth factor gene expression by intimai cells in healing polytetrafluoroethylene grafts. J Vase Surg 1990; 11: 580-585.
112. Golden MA, Au YPT, Kirkman TR et al. Platelet derived growth factor activity and mRN A expression in healing vascular grafts in baboons. J din Im est 1991 ; 87: 406-414.
113. Lindner V. Lappi DA. Baird A. Majack RA, Reidy MA. Role of basic fibroblast growth factor in vascular lesion formation. Circ Res 1991; 68: 106-113.
114. Lindner V, Reidy MA. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against fibroblast growth factor. Proc Natl Aead Sei 1991 ; 88: 3739-3743.
115. @RT = 115. Fuster V. Chesebro JH. Role of platelets and platelet inhibitors in aortocoronary vein-graft disease, emulation 1986; 73: 227-232.
116. Underwood MJ, More RS, de Bono DP, Gershlick AH. Antiplatelet therapy following coronary artery surgery. J Roy Soc Med 1994; 87: 63-65.
117. Bryan AJ. Sassen LM, Violaris AG et al. Subcutaneous heparin and myointimal proliferation in arteriovenous bypass grafts. J Thorae Cardiovast Surg 1992; 103: 170-171.
118. Schwartz RS, Holmes DR, Topol EJ. The restenosis paradigm revisited; an alternative proposal for cellular mechanisms. J Am Coll Cardiol 1992; 20: 1284-1293.
119. Ferns GA, Raines EW, Srugel KH et al. Inhibition of neointimal smooth muscle cell accumulation after angioplasty by an antibody to PDGF. Science 1991; 253: 1129-1132.
120. Shi Y, Hutchinson HG, Hall DJ et al. Down regulation of c-myc expression by antisense oligonucleotides inhibits proliferation of human smooth muscle cells. Circulation 1993; 88: 1190-1195.
121. Nabel EG. Pompili VJ, Plautz GE, Nabel GJ. Gene transfer and vascular disease. Caraiovasc Res 1994; 28: 445-455.
122. Bulkley BH, Hutchins GM. Accelerated atherosclerosis. A morphological study of 97 saphenous vein coronary artery bypass grafts. Circulation 1977; 55: 163-169.
123. Mautner SL, Mautner GC, Hunsberger SA, Roberts WC. Comparison of composition of atherosclerotic plaques in saphenous vein used as aortocoronary bypass conduits with plaques in native coronary arteries in the same men. Am J Cardiol 1992; 70: 1380.-1387.
124. Bourassa MG, Fisher LD, Campeau L et al. Long-term fate of bypass grafts: The Coronary Artery Surgery Study (CASS) and Montreal Heart Institute experiences. Circulation 1985; 72 (Suppl V): V-7I-V-78.
125. Solymoss BC, Leung TK, Pelletier LC, Campeau L. Pathological changes in coronary artery saphenous vein grafts and related aetiological factors. Cardiovasc Clin 1991; 21(2): 45-65.
126. Blankenhorn DH. Nessim SA, Johnson RLet al. Beneficial effects of combined colestipolniacin therapy on coronary atherosclerosis and venous bypass grafts, y Am MedAssnc 1987; 257: 3233-3240.
127. FitzGibbon GM. Leach AJ, Kafka HP. Atherosclerosis of coronary artery bypass grafts and smoking. Can MeJ AssoeJ 1987: 136: 45-47.
128. Solymoss BC. Nadeau P. Millette D el al. Late thrombosis of saphenous vein coronary bypass grafts related to risk factors. Circulation 1988: 78(Suppl I): M40-I-143.
129. Engblom E, Ronnemaa T. Hamalainen H et al. Coronary heart disease risk factors before and after bypass surgery: results of a controlled trial on multifactorial rehabilitation. Eur Heart J 1992: 13: 232-237.
130. Yusut S, Zucker D, Peduzzi P et al. Effect of coronary artery bypass graft surgery on survival: overview of 10 year results from randomised trials by the coronary artery bypass graft surgery trialists collaboration. Lancet 1994: 344: 563-570.
131. Cooper GJ. Angelini GD. Flow through arterial grafts. In: Arterial grafts in mocardial rerascttlarisatioii. Angelini GD. Dion R. Eds. London: Edward Arnold. 1996.